Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 2:47 pm Purchase | 2025-12-31 | 13G | XPERI INC XPER | Clearline Capital LP | 2,949,895 6.400% | 2,949,895 (New Position) | Filing History |
| 2026-02-17 2:44 pm Sale | 2025-12-31 | 13G | MAGNACHIP SEMICONDUCTOR CORP N MX | Clearline Capital LP | 1,461,036 4.100% | -439,140 (-23.11%) | Filing History |
| 2026-02-17 2:40 pm Purchase | 2025-12-31 | 13G | HERON THERAPEUTICS INC HRTX | Clearline Capital LP | 12,235,239 6.700% | 2,522,712 (+25.97%) | Filing History |
| 2025-11-26 10:15 am Purchase | 2025-09-30 | 13G | HERON THERAPEUTICS INC HRTX | Clearline Capital LP | 9,712,527 5.300% | 9,712,527 (New Position) | Filing History |
| 2025-02-12 4:28 pm Purchase | 2024-12-31 | 13G | MAGNACHIP SEMICONDUCTOR CORP N MX | Clearline Capital LP | 1,900,176 5.100% | 1,900,176 (New Position) | Filing History |
| 2025-02-12 4:25 pm Sale | 2024-12-31 | 13G | THERAPEUTICSMD INC TXMD | Clearline Capital LP | 635,222 5.500% | -1,400 (-0.22%) | Filing History |
| 2024-11-12 4:40 pm Purchase | 2024-09-30 | 13G | THERAPEUTICSMD INC TXMD | Clearline Capital LP | 636,622 5.520% | 636,622 (New Position) | Filing History |